that under oxidized conditions the ability of glucagon to alter each parameter was decreased without affecting the concentration of hormone at which half-maximal effects occurred. 5. The phosphodiesterase inhibitor 3-isobutyl-1-methylxanthine (0.05mM) significantly reversed the inhibitory effects of pyruvate on glucagon-stimulated glucose output. 6. For exogenously added cyclic [3H]AMP (0.1 mM), oxidized conditions decreased the stimulatory effect on glucose output as well as the intracellular concentration of cyclic AMP attained, but did not alter the amount of cyclic [3H]AMP taken up. 7. The effects of lactate, pyruvate, NAD+ and NADH on cyclic AMP phosphodiesterase activities of rat hepatocytes were examined. 8. NADH (0.01-1 mM) inhibited the low-Km enzyme, particularly that which was associated with the plasma membrane. 9. The inhibition of membrane-bound cyclic AMP phosphodiesterase by NADH was specific, reversible and resulted in a decrease in the maximal velocity ofthe enzyme. 10. It is proposed that regulation of the membrane-bound low-Km cyclic AMP phosphodiesterase by nicotinamide nucleotides provides the molecular basis for the effect of redox state on the hormonal control of hepatocyte metabolism by glucagon.
and urea synthesis in isolated hepatocytes from 48 h-starved rats; under oxidized conditions (with lOmM-pyruvate), lOnM-glucagon had no effect on either of these rates. 3. The ability of glucagon to alter the concentration of 3': 5'-cyclic AMP and the rates of glucose output, glycogen breakdown and glycolysis in cells from fed rats were each affected by a change in the extracellular [lactate]/[pyruvate] ratio; minimal effects of glucagon occurred at low [lactate]/[pyruvate] ratios. 4. Dose-response curves for glucagon-mediated changes in cyclic AMP concentration and glucose output indicated that under oxidized conditions the ability of glucagon to alter each parameter was decreased without affecting the concentration of hormone at which half-maximal effects occurred. 5. The phosphodiesterase inhibitor 3-isobutyl-1-methylxanthine (0.05mM) significantly reversed the inhibitory effects of pyruvate on glucagon-stimulated glucose output. 6. For exogenously added cyclic [3H]AMP (0.1 mM), oxidized conditions decreased the stimulatory effect on glucose output as well as the intracellular concentration of cyclic AMP attained, but did not alter the amount of cyclic [3H]AMP taken up. 7. The effects of lactate, pyruvate, NAD+ and NADH on cyclic AMP phosphodiesterase activities of rat hepatocytes were examined. 8. NADH (0.01-1 mM) inhibited the low-Km enzyme, particularly that which was associated with the plasma membrane. 9. The inhibition of membrane-bound cyclic AMP phosphodiesterase by NADH was specific, reversible and resulted in a decrease in the maximal velocity ofthe enzyme. 10. It is proposed that regulation of the membrane-bound low-Km cyclic AMP phosphodiesterase by nicotinamide nucleotides provides the molecular basis for the effect of redox state on the hormonal control of hepatocyte metabolism by glucagon.
It has been previously reported that the ability of glucagon to stimulate glucose release by isolated rat hepatocytes and perfused liver is affected by the redox state of the cytosolic NAD+ couple (Clark et al., 1977 Isolated hepatocytes were prepared from fed or 48h-starved rats (180-220g) essentially as described by Berry & Friend (1969) , with the omission of hyaluronidase. Buffers were equilibrated with 02/CO2 (19:1) before use.
Unless indicated otherwise, incubations were conducted at 37°C with shaking (90 oscillations/min) in stoppered vials of 20ml capacity with substrate (in 0.02ml of 0.9% NaCl solution) and hormone (in 0.05 ml of 0.9 % NaCl solution) in a total volume of 1.2ml of pH7.4 (Dawson, 1969) , containing 1.3mM-Ca2+. After addition of the cells (approx. 65mg wet wt.) each vial was gassed with the 02/CO2 mixture and stoppered. The reactions were terminated by the addition of 0.5ml of 6 % (w/v) HCI04.
The method for the separation of hepatocytes from medium was based on the silicone-oil centrifugation method of La Noue et al. (1972) . A sample of the cell-suspension incubation medium (0.2ml) was layered on the surface of 0.5ml of silicone-oil mixture (7: 1, v/v: type 550 fluid + type 200 fluid, viscosity 1.5x 10-4Pa s) placed above 0.05 ml of 6% (w/v) HC104 contained in an Eppendorf Microfuge tube (total capacity 1.5 ml). Each sample was centrifuged for 30s (Eppendorf Zentrifuge), after which time separation was complete. A sample (0.04ml) was carefully removed from the bottom HCl04 layer and neutralized to pH 7.0 with 1 M-KOH.
Analytical determinations
Glucose output (cells from fed rats) and gluconeogenesis (cells from starved rats) were determined by measuring the total glucose content of the cells plus medium. Analyses for glucose were conducted on the acid supernatant fluid by using the glucose oxidase/ peroxidase method (Werner et al., 1970) . Since the rate of gluconeogenesis from 10mM-lactate was approx. 0.6,umol/min per g wet wt. for cells from fed rats (results not shown), the rate of glucose output of 2-2.5pmol/min per g wet wt. essentially represented glucose output from substrates other than the added lactate or pyruvate (e.g. glycogen). Urea was determined by the urease method of Fawcett & Scott (1960 Pyruvate concn. (mM) Fig. 1 
Results
It has previously been reported by three groups (Zahlten et al., 1973; Garrison & Haynes, 1973; Rognstad, 1975) (Clark et al., 1977) and show that glucagon-mediated effects on glucose output (Fig. 2a) , glycogenolysis (assessed by loss of radioactivity from prelabelled glycogen; The next group of experiments (Figs. 3-6) were conducted in an attempt to locate the possible site, between glucagon-receptor interaction and change in glycogenolytic rate, where redox state (in particular pyruvate) exerted its influence. Fig. 3 shows the effects of 10mM-lactate and 10mM-pyruvate on glucagon-mediated changes in cyclic AMP concentration. Glucagon (1 nM) increased cyclic AMP approx. 8-fold in 1 min (Fig. 3c ). This increase was glucose output were examined (Fig. 4) . Most significantly the data showed that the concentration of glucagon required to achieve half-maximal production of cyclic AMP or glucose output was unaffected by redox state, even though oxidized conditions (produced by adding 10mM-pyruvate) markedly decreased the overall response to glucagon. In addition, the phosphodiesterase inhibitor 3-isobutyl-1-methylxanthine when added with pyruvate significantly increased glucagon-stimulated glucose output (Fig. 4b) by decreasing by approximately one order of magnitude the concentration of hormone required to produce half-maximal effects.
An experiment similar to that of Fig. 4 (b) was undertaken to determine the effect of extracellular lactate and pyruvate on extracellular cyclic AMPmediated glucose output (Fig. 5) . In the presence of 10mM-pyruvate there was no significant effect of the cyclic nucleotide on the rate of glucose output. On this basis an effect of redox state on a reaction after adenylate cyclase that affected cyclic AMP concentration seemed likely. Fig. 6 shows the effect of extracellular lactate and pyruvate on (a) the intracellular concentration of cyclic AMP, (b) the uptake of radioactivity and (c) the rate of glucose output that occurred after the addition of 0.1 mM-cyclic _~~~~~1-- (Fig. 6b) , a pronounced effect on the intracellular cyclic AMP concentration occurred (Fig. 6a) NADH concn. (mM) Fig. 7 Table 1 shows that both low-Km activities were affected by one of the four compounds tested. Most significantly, NADH strongly inhibited the membrane enzyme, with relatively less effect and no effect on the cytosolic lowand high-Km enzymes respectively. The inhibitory effect was apparent directly after mixing with NADH (Fig. 7a) , and concentrations as low as 5pM-NADH produced significant inhibition of the membrane low-Km activity. Half-maximal inhibitory effects by NADH were obtained at approx. 204uM-NADH (Fig. 7b) . To assess the possibility that the inhibitory effect of NADH was due to contaminants, a small portion (0.1 ml of 10mM-NADH) was made to react with an equal quantity of sodium pyruvate and 2 units of crystalline lactate dehydrogenase; the small inhibitory effect of this reaction mixture on phosphodiesterase activity corresponded to remaining assayable content of NADH (results not shown). Further, NADH (1 mM) did not inhibit the snake-venom 5'-nucleotidase, a component of the phosphodiesterase assay system (Arch & Newsholme, 1976) . Table 2 shows the effects of NADH and related compounds on the activity of the low-Km membrane AMP phosphodiesterase. Whereas 1 mM-NADH inhibited the enzyme by 65-70%, the same concentration of NAD+, NADP+ or lactate had no effect. A 1 mm solution of NADPH, dithiothreitol, reduced glutathione or 2-mercaptoethanol had slight effects (15-24% inhibition). The inclusion of 1.3 pM-Ca2+ produced insignificant change in the control rate or the inhibition produced by NADH. 3-Isobutyl-1-methylxanthine (0.05mM) inhibited the enzyme by 87%.
To establish whether the inhibitory effect of 1 mM-NADH was reversible for the membrane low-Km The data of Fig. 8(a) show the substrate-saturation kinetics for the low-Km membrane cyclic AMP phosphodiesterase in the presence and absence of the inhibitor (1 mM-NADH). Measurement of enzyme rate for the range 0.025-1 uM-cyclic AMP showed that this enzyme preparation contained mainly lowKm activity, although some contamination with an activity ofhigh Km was also noted. Thus the inhibitory effects of NADH were examined mainly in the substrate range 0.025-0.1 gM (Fig. 8b) . These results indicated the apparent Km of the enzyme to be approx. 0.2AM and that NADH inhibited the enzyme by decreasing the Vn,ax.. Subcellular fractionation of the hepatocytes was undertaken to ascertain whether the low-Km phosphodiesterase activity was associated with the plasma Effect of NADH on the activity of hepatocyte membrane low-Km phosphodiesterase A solubilized hepatocyte membrane fraction containing low-Km phosphodiesterase was prepared and assayed as described in the Materials and Methods section. The initial velocity was measured over a 5 min period, during which the rate was linear and less than 25% of the substrate was consumed.
Additions were none (A) and 1 mM-NADH (-). The data are from duplicate assays for two liver cellmembrane preparations and are presented in (b) by a Lineweaver-Burk plot, where the lines have been fitted by eye. membrane and whether NADH inhibition occurred for a more pure preparation of the enzyme. Fractionation of the microsomal pellet by discontinuoussucrose-density-gradient centrifugation (Table 3) by the method of Touster et al. (1970) showed that the low-Km cyclic AMP phosphodiesterase activity was 1978
812
.t Table 3 . Cyclic AMP phosphodiesterase activities in subcellular fractions ofisolated hepatocytes Isolated hepatocytes (approx. 2g wet wt.) were homogenized as described by Wisher & Evans (1977) for the isolation of plasma membranes. Fractionation of the homogenate and the microsomal pellet was conducted as described by Touster et al. (1970) . Methods for the determination of protein, cyclic AMP phosphodiesterase, 5'-nucleotidase and glucose 6-phosphatase were as described in the text. The terms 'homogenate' and 'microsomal (P) fraction' are as used by Touster et al. (1970) located in two adjacent fractions: (a) the 8/34% (w/v) sucrose interface, which contained predominantly plasma membranes and was enriched with 5'-nucleotidase; (b) the 8% (w/v) sucrose layer, which was also partially enriched with 5'-nucleotidase. NADH (1 mM) inhibited the cyclic AMP phosphodiesterase activity in each fraction; the highestspecific-activity fraction was inhibited to the greatest extent (Table 3) .
Discussion
Redox state and glucagon action Thus far the involvement of redox state in hormone action has received little attention. Parrilla et al. (1975 Parrilla et al. ( , 1976 have noted that the glucagon-mediated enhancement of gluconeogenesis in isolated perfused livers from starved rats was accompanied by a more reduced cytosolic and mitochondrial redox state of the NAD system. Siess et at. (1977) Williamson (1969) . However, the finding that glycodiazine, an inhibitor of lipolysis (Menahan & Wieland, 1969) , does not prevent the glucagon stimulation of gluconeogenesis (Frolich & Wieland, 1971 ) has cast some doubt on this hypothesis. Thus the mechanism by which the cell becomes more reduced after glucagon administration remains to be established, and as yet there are no data to indicate whether a change in redox state Vol. 176 results from, or leads to, the stimulation of gluconeogenesis by this hormone.
From an entirely different viewpoint Low, Crane and their co-workers have examined a hormoneregulated redox function in plasma membranes (Low & Crane, 1976; Crane & Low, 1976; Low & Werner, 1976) . They have reported that: (i) NADH inhibits adenylate cyclase in fat-cell plasma-membranes; (ii) NADH dehydrogenase is present in plasma membranes; (iii) the NADH dehydrogenase activity in the liver cell plasma membrane is activated by glucagon at concentrations of the hormone that stimulate adenylate cyclase activity; (iv) the addition of 3 mM-lactate (preincubated with the cells for 45min) together with 3-isobutyl-1-methylxanthine to isolated hepatocytes resulted in a decreased production of cyclic AMP by glucagon (Zederman et al., 1977) . In the present studies without the addition of a phosphodiesterase inhibitor, or an extensive preincubation period with lactate, no inhibitory effect of lactate on glucagon-mediated cyclic AMP production was noted.
In one other system (Ehrlich ascites-tumour cells) it has been observed that quinacrine, an agent that inhibits plasma-membrane NADH reductaso, inhibited methylaminoisobutyrate uptake (Garcia-Sancho et.al., 1977) , an effect that could not be simulated by agents such as rotenone, cyanide and azide, which each appreciably decreased cellular ATP. These workers proposed that the NADH dehydrogenase present in plasma-membrane preparations (Samudio & Canessa, 1966; Ferber et al., 1972; Low & Crane, 1976; Crane & Low, 1976) participates in the energization of both Na+-dependent and Na+-independent amino acid transport, allowing the utilization of reducing equivalents which can be made available by a shuttle from the mitochondria to the cytoplasm. It remains to be seen whether hormonal effects on amino acid transport are related to changes in the plasma NADH dehydrogenase activity.
In the present work data are presented to show that glucagon-mediated glycogenolysis in hepatocytes from fed rats is controlled by the redox state and that this modification of glucagon efficacy may be regulated by NADH acting to inhibit the membrane-bound low-Km cyclic AMP phosphodiesterase. The present observations extend the findings of Zahlten et al. (1973) with hepatocytes from starved rats, where glucagon was noted to inhibit gluconeogenesis from pyruvate while stimulating gluconeogenesis from lactate, and earlier ones with the isolated perfused rat liver, where glucagon consistently stimulated gluconeogenesis from lactate to a greater extent than from pyruvate (Garrison & Haynes, 1973; see their Table VI for a summary of various groups' data). Zahlten et al. (1973) explained their observations on the basis that, since glucagon inhibited pyruvate dehydrogenase (determined from effects on the decarboxylation of [1-14C]pyruvate), the production of reducing equivalents for gluconeogenesis became limiting. This explanation appeared likely for gluconeogenesis in cells from starved rats, particularly since it was overcome by the inclusion of ethanol (Garrison & Haynes, 1973; Zahlten et al., 1973) , but was considered unsatisfactory for a similar related loss of glucagon efficacy in stimulating glycogenolysis in cells from fed rats (Clark et al., 1977) . In that previous work (Clark et al., 1977) It is generally accepted that there are at least two forms of cyclic AMP phosphodiesterase in rat liver. The two forms differ in a number of aspects, but primarily in their affinity for the substrate: the high-Km (low-affinity) enzyme is usually soluble and the low-Km (high-affinity) enzyme is both soluble and particulate. In the present study three cyclic AMP phosphodiesterase activities were detected: a soluble high-Km enzyme, a soluble low-Km enzyme and a membrane-bound low-Km enzyme. Contamination of the membrane fraction with high-Km activity was assumed to result from incomplete disruption of the cells during isolation, although some high-Km activity has been reported to be associated with the membrane fraction (Tria et al., 1976; Gumaa et al., 1977) . Both the membrane and the soluble low-Km enzymes were inhibited by 1 mM-NADH, although the membrane enzyme was more markedly inhibited. The specificity of the inhibitory effect appeared to be high; only slight inhibitory effects of NADPH, dithiothreitol, lactate, reduced glutathione and 2-mercaptoethanol were noted. In addition, the inhibitory effect by NADH was reversible and kinetic examination indicated that I mM-NADH decreased the maximal velocity without affecting the Km. Furthermore the low-Km NADH-sensitive enzyme appeared to be associated with the plasma-membrane fraction of hepatocytes.
To our knowledge NADH has not been previously reported as an inhibitor of cyclic AMP phosphodiesterase (for example, see the review by Amer & Kreighbaum, 1975) . The present data indicate that the concentration at which half-maximal inhibition is attained is approx. 20,pM. The total hepatic concentrations of NADH and NAD+ (free+ bound) are in the ranges 40-500 and 500-800nmol/g per wet wt. respectively (Bucher, 1970 (Krebs & Veech, 1970) , the concentration of free NADH is of the order of lpM, which is well below the minimum concentration to affect phosphodiesterase. Thus the proposal for a physiologically important regulation of the membrane-bound cyclic AMP phosphodiesterase by NADH is based on the assumption that there is a constant equilibrium between the redox state of free and bound nicotinan)ide nucleotides. Bucher, 1970) .
Regulation by NADH .of both adenylate cyclase (Low & Werner, 1976 ) and cyclic AMP phosphodiesterase in an inhibitory capacity might appear contradictory. The present data, together with those 1978 of Low and co-workers, suggest the possibility of a 'redox optimum' as an overriding control of glucagon efficacy, where both highly reduced conditions and highly oxidized conditions decrease the response. Under normal conditions and in the absence of phosphodiesterase inhibitor, the effect of NADH on cyclic AMP phosphodiesterase would appear to be the most significant [i.e. no significant inhibitory effect of 10mM-lactate on glucagon stimulated glycogenolysis was noted previously (Clark et al., 1977) or in the present studies (Figs. 2 and 4) ].
Various laboratories have reported on the control of the intracellular concentration of cyclic AMP through hormonal modulation of a specific phosphodiesterase (see Appleman et al., 1973 , for review). Insulin has been reported to increase in adipose tissue the activity of a particulate low-Km cyclic AMP phosphodiesterase (Loten & Sneyd, 1970; Manganiello & Vaughan, 1973; Zinman & Hollenberg, 1974; Sakai et al., 1974; Lovell-Smith et al., 1977) and in some liver tissue a plasma-membrane-bound low-Km enzyme has been reported to be activated by insulin after treatment in vivo or in vitro (House et al., 1972) . More recently, isolated hepatocytes incubated in the presence of insulin showed increased phosphodiesterase activity in a plasma-membrane-containing fraction (Tria et al., 1976; Loten et al., 1978) . Even though insulin also lowers the glucagon-mediated increase in reduction of the redox state (Parrilla et al., 1975 (Parrilla et al., , 1976 , there is no evidence as yet that this relates to the present observed inhibition of the enzyme by NADH.
